445 related articles for article (PubMed ID: 29843224)
1. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
[TBL] [Abstract][Full Text] [Related]
2. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
[TBL] [Abstract][Full Text] [Related]
3. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
[TBL] [Abstract][Full Text] [Related]
4. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
Front Immunol; 2018; 9():1274. PubMed ID: 29922294
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia.
Memarian A; Nourizadeh M; Masoumi F; Tabrizi M; Emami AH; Alimoghaddam K; Hadjati J; Mirahmadian M; Jeddi-Tehrani M
Tumour Biol; 2013 Feb; 34(1):531-42. PubMed ID: 23179394
[TBL] [Abstract][Full Text] [Related]
6. Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia.
Wan Y; Zhang C; Xu Y; Wang M; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang Y; Wang J
BMC Cancer; 2020 May; 20(1):472. PubMed ID: 32456622
[TBL] [Abstract][Full Text] [Related]
7. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
8. After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia.
Delia M; Carluccio P; Mestice A; Frappampina R; Albano F; Specchia G; Musto P
J Immunol Res; 2020; 2020():2134647. PubMed ID: 33204734
[TBL] [Abstract][Full Text] [Related]
9. Increased CD200 expression in post-transplant lymphoproliferative disorders correlates with an increased frequency of FoxP3(+) regulatory T cells.
Vaughan JW; Shi M; Horna P; Olteanu H
Ann Diagn Pathol; 2020 Oct; 48():151585. PubMed ID: 32829067
[TBL] [Abstract][Full Text] [Related]
10. Impact of Concomitant Aberrant CD200 and BCL2 Overexpression on Outcome of Acute Myeloid Leukemia: A Cohort Study from a Single Center.
Tiribelli M; Michelutti A; Cavallin M; Di Giusto S; Fanin R; Damiani D
Turk J Haematol; 2021 Jun; 38(2):119-125. PubMed ID: 33596632
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of T cell activation markers and upregulation of Tregs in bone marrow and peripheral blood in acute myeloid leukemia patients.
Fang J; Zhang R; Lin X; Xu Y; Huang K; Saw PE
Hematology; 2023 Dec; 28(1):2219554. PubMed ID: 37288810
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia.
Aref S; Abousamra N; El-Helaly E; Mabed M
Asian Pac J Cancer Prev; 2020 Mar; 21(3):743-748. PubMed ID: 32212802
[TBL] [Abstract][Full Text] [Related]
14. High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.
Tiribelli M; Raspadori D; Geromin A; Cavallin M; Sirianni S; Simeone E; Bocchia M; Fanin R; Damiani D
Leuk Res; 2017 Jul; 58():31-38. PubMed ID: 28407515
[TBL] [Abstract][Full Text] [Related]
15. Expression of Th17 and CD4
Xiang M; Guo L; Ma Y; Li Y
Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
[TBL] [Abstract][Full Text] [Related]
16. [Expression of Tim-3 on natural killer cells in patients with acute myeloid leukemia and its clinical significance].
Ma JF; Li CX; Wu DP; Sun ZL; Yan CL
Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):755-758. PubMed ID: 31648478
[No Abstract] [Full Text] [Related]
17. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S
Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia.
Kandeel EZ; Madney Y; Eldin DN; Shafik NF
Exp Mol Pathol; 2021 Feb; 118():104597. PubMed ID: 33358743
[TBL] [Abstract][Full Text] [Related]
19. ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.
Tiribelli M; Geromin A; Cavallin M; Di Giusto S; Simeone E; Fanin R; Damiani D
Eur J Haematol; 2017 Sep; 99(3):269-274. PubMed ID: 28618016
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.
Damiani D; Tiribelli M; Raspadori D; Sirianni S; Meneghel A; Cavalllin M; Michelutti A; Toffoletti E; Geromin A; Simeone E; Bocchia M; Fanin R
Oncotarget; 2015 Oct; 6(30):30212-21. PubMed ID: 26338961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]